A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2001
12/13/2001	CA2411354A1 Methods of treating viral diseases with il-18 and il-18 combinations
12/13/2001	CA2411351A1 Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors
12/13/2001	CA2411342A1 Non-antibacterial tetracycline as anti-fungal agents
12/13/2001	CA2411340A1 Substituted stilbenes as glucose uptake enhancers
12/13/2001	CA2411243A1 Use of sulodexide for the treatment of diabetic nephropathy
12/13/2001	CA2411084A1 Thiophene derivatives useful as anticancer agents
12/13/2001	CA2411065A1 Thiazolidinedione salt for treatment of diabetes mellitus
12/13/2001	CA2411064A1 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydriodide as pharmaceutical
12/13/2001	CA2411062A1 Benzamide ligands for the thyroid receptor
12/13/2001	CA2411013A1 6-phenylpyrrolopyrimidinedione derivatives
12/13/2001	CA2411010A1 Tetracyclic diketopiperazine compounds as pdev inhibitors
12/13/2001	CA2410993A1 Starter kit for low dose oral contraceptives
12/13/2001	CA2410577A1 Method for treating respiratory disorders associated with pulmonary elastic fiber injury
12/13/2001	CA2410509A1 Indolinone derivatives as protein kinase/phosphatase inhibitors
12/13/2001	CA2410409A1 Antitumoral compounds
12/13/2001	CA2409123A1 Heterocycle derivatives and methods of use
12/13/2001	CA2409015A1 Caspase inhibitors and uses thereof
12/13/2001	CA2408612A1 Aqueous chondroprotective compositions having defined ph limitations for efficacious delivery
12/13/2001	CA2408611A1 Kits and methods for optimizing the efficacy of chondroprotective compositions
12/13/2001	CA2408610A1 Low carbohydrate compositions, kits thereof, and methods of use
12/13/2001	CA2408609A1 Compositions, kits, and methods for promoting defined health benefits
12/13/2001	CA2408542A1 Prostaglandin compounds for treating congestive heart failure
12/13/2001	CA2407164A1 Bicyclic cyclohexylamines and their use as nmda receptor antagonists
12/13/2001	CA2378754A1 Treating smooth muscle hyperactivity with (r)-oxybutynin and (r)-deseth yloxybutynin
12/12/2001	EP1162265A2 Human PEM as a target for fertility control and Alzheimer therapy
12/12/2001	EP1162263A1 Nucleozymes
12/12/2001	EP1162207A1 Amylin agonist peptides and uses therefor
12/12/2001	EP1162206A2 Peptide nucleic acids
12/12/2001	EP1162201A2 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives
12/12/2001	EP1162196A1 Fused-ring compounds and use thereof as drugs
12/12/2001	EP1162194A1 Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use
12/12/2001	EP1161956A1 Medicinal compositions
12/12/2001	EP1161950A1 Use of diazepinoindoles for the treatment of chronic obstructive pulmonary disease
12/12/2001	EP1161949A1 Use od diazepinoindoles for the treatment of chronic obstructive pulmonary disease
12/12/2001	EP1161948A2 Pharmaceutical or food composition for treatment of brain edema
12/12/2001	EP1161947A2 Oral antibacterial compositions and method for the improvement of gastrointestinal absorption of penem or carbapenem antibiotics
12/12/2001	EP1161946A2 Soluble analogs of probucol
12/12/2001	EP1161945A2 Pharmaceutical composition based on proline, glycine and lysine used in the therapy for the healing of tendon lesions and open wounds
12/12/2001	EP1161944A1 Drugs, foods and oral compositions containing stilbene-type compounds
12/12/2001	EP1161943A2 Methods for identifying compounds for inhibition of neoplastic lesions, and pharmaceutical compositions containing such compounds
12/12/2001	EP1161942A2 Ophthalmic composition
12/12/2001	EP1161884A1 Proenergetic food supplement based on NADH, Octacosanol and Vitamin E
12/12/2001	EP1161564A1 SCREENING OF ANTIVIRAL COMPOUNDS TARGETED TO THE HIV-1 gp41 CORE STRUCTURE
12/12/2001	EP1161542A1 Polysaturated fatty acid (pufa) elongase from caenorhabditis elegans
12/12/2001	EP1161534A1 Differential expression of organellar gene products
12/12/2001	EP1161530A1 Protein for blocking platelet adhesion
12/12/2001	EP1161518A2 Towelette product
12/12/2001	EP1161448A1 49 human secreted proteins
12/12/2001	EP1161447A1 50 human secreted proteins
12/12/2001	EP1161444A1 A novel inhibitor of programmed cell death
12/12/2001	EP1161442A2 Exocytosis pathway proteins and methods of use
12/12/2001	EP1161439A1 Xylo-lna analogues
12/12/2001	EP1161438A1 6-o-substituted macrolides having antibacterial activity
12/12/2001	EP1161436A1 Polyunsaturated fatty acid derivatives and their use
12/12/2001	EP1161434A1 Pyridopyranoazepine derivatives, preparation and therapeutic use
12/12/2001	EP1161433A1 Tyrosine kinase inhibitors
12/12/2001	EP1161432A1 Pharmaceutical composition based on polyaromatic compounds
12/12/2001	EP1161431A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
12/12/2001	EP1161430A2 Epothilon derivatives, method for the production and the use thereof as pharmaceuticals
12/12/2001	EP1161429A2 Heterocyclic compounds as adenosine deaminase inhibitors
12/12/2001	EP1161428A1 Pyrimidine compounds
12/12/2001	EP1161427A1 Improved process for asymmetric hydrogenation
12/12/2001	EP1161423A1 Thiazolyl urea derivatives and their utilization as antiviral agents
12/12/2001	EP1161422A1 Amine derivatives as protease inhibitors
12/12/2001	EP1161421A1 Inhibitors of protein tyrosine phosphatase
12/12/2001	EP1161419A1 Spirocyclic ketones and their use as tachykinin antagonists
12/12/2001	EP1161418A1 1-acyl-7-nitroindoline derivatives, their preparation and their use as photocleavable precursors
12/12/2001	EP1161415A2 N-cyanomethylamides as protease inhibitors
12/12/2001	EP1161412A1 Nuclear receptor arylating compounds
12/12/2001	EP1161410A1 Retinoid antagonists and use thereof
12/12/2001	EP1161280A1 Use of an integrin antagonist and a chemotherapeutic agent in the treatment of neoplasia
12/12/2001	EP1161279A1 Treatment of thrombosis by combined use of a factor xa inhibitor and aspirin, tissue plasminogen activator (tpa), a gpiib/iiia antagonist, low molecular weight heparin or heparin
12/12/2001	EP1161265A1 Method for the identification and removal of nits from hair
12/12/2001	EP1161263A1 Analgesic compositions comprising anti-epileptic compounds and methods of using same
12/12/2001	EP1161262A1 SURFACE LOCALIZED COLLIGIN/HsP47 IN CARCINOMA CELLS
12/12/2001	EP1161255A2 Methods and compositions for treating erectile dysfunction
12/12/2001	EP1161247A1 Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic
12/12/2001	EP1161246A2 Method of promoting mucosal hydration with certain uridine, adenine and cytidine diphosphates and analogs thereof
12/12/2001	EP1161245A1 Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula
12/12/2001	EP1161244A2 Use of 1,2,4-triazolo[1,5-a]pyrimidine derivatives for treating migraine
12/12/2001	EP1161243A2 Pharmaceutical compositions comprising a pyrimidine derivative and cyclodextrin
12/12/2001	EP1161242A1 Composition and method for treating diabetes
12/12/2001	EP1161241A1 Stable pharmaceutical application form for paroxetin anhydrate
12/12/2001	EP1161240A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
12/12/2001	EP1161239A2 3-cyclopropylmethoxy-4-difluoromethoxy-n-(3,5-dichloropyrid-4-yl)benzamide in the treatment of multiple sclerosis
12/12/2001	EP1161238A1 Amyotropic lateral sclerosis treatment with a combination of riluzole and an ampa receptor antagonist
12/12/2001	EP1161237A1 Protease inhibitors
12/12/2001	EP1161236A1 Dihydroxy open-acid and salts of hmg-co-a reductase inhibitors
12/12/2001	EP1161235A1 Combinations for the treatment of diseases involving angiogenesis
12/12/2001	EP1161234A2 Method for delivering benzidine prostaglandins by inhalation
12/12/2001	EP1161233A2 Lxr modulators
12/12/2001	EP1161232A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
12/12/2001	EP1161231A2 Method of inhibiting a chaperone protein
12/12/2001	EP1161230A1 Transdermal therapy system and method for producing the same
12/12/2001	EP1161228A2 Composition comprising isoquercetin and ascorbic acid in a sustained release form
12/12/2001	EP1161226A1 Phosphocholine linked prodrug derivatives
12/12/2001	EP1161225A1 Metered dose inhalers with isobutane as propellant
12/12/2001	EP1161157A1 Food complement and method for cosmetic treatment based on a grape extract rich in polyphenols
12/12/2001	EP1161150A1 Therapeutic antimicrobial compositions
12/12/2001	EP1161146A1 Deep penetrating antimicrobial compositions

1 ... 5946 5947 5948 5949 5950 5951 5952 5953 5954 5955 5956 5957 5958 5959 5960 5961 5962 5963 5964 5965 5966 ... 7860